Literature DB >> 6303485

Pharmacological characterization of the opioid receptor in the submucous plexus of the guinea-pig oesophagus.

Y Kamikawa, Y Shimo.   

Abstract

1 The cholinergically mediated electrically-induced contractions of the submucous plexus-longitudinal muscularis mucosae preparation of the guinea-pig oesophagus were used to study the actions of opioid peptides and morphine. 2 The twitch contractions of the tissue (0.1 Hz, 0.5 ms, supramaximal voltage) were inhibited by all the opioid peptides and morphine in a concentration-dependent manner. The order of potency was dynorphin-(1-13) greater than alpha-neo-endorphin greater than beta-endorphin greater than [D-Ala2]-methionine-enkephalin much greater than alpha-endorphin, methionine-enkephalin, leucine-enkephalin and morphine. 3 The inhibitory actions of dynorphin-(1-13) (20 nM), alpha-neo-endorphin (100 nM) and beta-endorphin (3 microM) were completely reversed either by naloxone (1 microM) or by morphine (100 microM). The Ke values of naloxone against dynorphin-(1-13) and alpha-neo-endorphin were 30 and 25 nM, respectively. 4 Increasing the concentration of calcium from 1.8 to 3.6 mM in Tyrode solution decreased the sensitivity of the tissue to dynorphin-(1-13) 7.4 times and to alpha-neo-endorphin 462 times. 5 The inhibitory actions of dynorphin-(1-13) (100 nM) and alpha-neo-endorphin (300 nM) were inversely related to stimulus frequency, being most active at low frequencies (0.1-1 Hz), and least active at high (30 Hz). 6 Exogenously applied acetylcholine produced concentration-dependent contractions of the isolated muscularis mucosae, with an EC50 of 72.6 +/- 4.5 nM. The contractile response of the oesophagus to acetylcholine was not affected by the pretreatment of the tissue with dynorphin-(1-13) (100 nM), alpha-neo-endorphin (300 nM) or beta-endorphin (3 microM). 7 It is concluded that the submucous plexus-longitudinal muscularis mucosae of the guinea-pig oesophagus is inhibited by opioid peptides acting at prejunctional opioid receptors, probably of the kappa-subtype.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6303485      PMCID: PMC2044750          DOI: 10.1111/j.1476-5381.1983.tb09422.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

1.  Dynorphin-(1-13), an extraordinarily potent opioid peptide.

Authors:  A Goldstein; S Tachibana; L I Lowney; M Hunkapiller; L Hood
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

2.  Kappa opioid properties of dynorphin and its peptide fragments on the guinea-pig Ileum.

Authors:  K Yoshimura; J P Huidobro-Toro; N M Lee; H H Löh; E L Way
Journal:  J Pharmacol Exp Ther       Date:  1982-07       Impact factor: 4.030

3.  A characterization of dynorphin-(1-13) on the guinea pig ileal longitudinal muscle.

Authors:  J L Vaught
Journal:  Eur J Pharmacol       Date:  1981-12-17       Impact factor: 4.432

Review 4.  Multiple opiate receptors in peripheral tissue preparations.

Authors:  M Wüster; R Schulz; A Herz
Journal:  Biochem Pharmacol       Date:  1981-07-15       Impact factor: 5.858

5.  Antagonistic effect of compound 48/80 on the inhibitory actions of morphine and methionine-enkephalin on electrically-induced contractions of the guinea-pig ileum.

Authors:  Y Kamikawa; Y Shimo
Journal:  Br J Pharmacol       Date:  1978-12       Impact factor: 8.739

6.  Leu-enkephalin-like material in nerves and enterochromaffin cells in the gut. An immunohistochemical study.

Authors:  J Alumets; R Håkanson; F Sundler; K J Chang
Journal:  Histochemistry       Date:  1978-07-12

7.  Agonist and antagonist actions of morphine-like drugs on the guinea-pig isolated ileum.

Authors:  E A Gyand; H W Kosterlitz
Journal:  Br J Pharmacol Chemother       Date:  1966-09

8.  Pharmacological characterization of the epsilon-opiate receptor.

Authors:  R Schulz; M Wüster; A Herz
Journal:  J Pharmacol Exp Ther       Date:  1981-03       Impact factor: 4.030

9.  Interactions between morphine and the opioid-like peptides in the rat vas deferens.

Authors:  F Huidobro; J P Huidobro-Toro; H Miranda
Journal:  Br J Pharmacol       Date:  1980-12       Impact factor: 8.739

10.  Inhibitory actions of catecholamines on electrically induced contractions of the submucous plexus-longitudinal muscularis mucosae preparation of the guinea-pig oesophagus.

Authors:  Y Kamikawa; Y Shimo; K Uchida
Journal:  Br J Pharmacol       Date:  1982-06       Impact factor: 8.739

View more
  8 in total

1.  Possible regulatory role of dynorphin A in the urinary bladder.

Authors:  A Berggren; A Dahlström; A Rubenson; U Sillén
Journal:  J Neural Transm Gen Sect       Date:  1992

2.  Pharmacological analysis of the calcium-dependence of mu-receptor agonism.

Authors:  I G Dougall; P Leff
Journal:  Br J Pharmacol       Date:  1987-12       Impact factor: 8.739

3.  Pharmacological characterization of the histamine receptor in the isolated muscularis mucosae of the guinea-pig oesophagus.

Authors:  S Fujinuma; Y Kamikawa; Y Shimo
Journal:  Br J Pharmacol       Date:  1985-11       Impact factor: 8.739

4.  Pharmacological properties of mechanical responses of the rat oesophageal muscularis mucosae to vagal and field stimulation.

Authors:  D Bieger; C Triggle
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

5.  Opioid receptor types on adrenergic nerve terminals of rabbit ear artery.

Authors:  H Fukuda; E Hosoki; Y Ishida; H Moritoki
Journal:  Br J Pharmacol       Date:  1985-11       Impact factor: 8.739

6.  On the opioid receptor subtype inhibiting the evoked release of 3H-noradrenaline from guinea-pig atria in vitro.

Authors:  H Fuder; M Buder; H D Riers; G Rothacher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-02       Impact factor: 3.000

7.  Contractile responses to substance P and related peptides of the isolated muscularis mucosae of the guinea-pig oesophagus.

Authors:  Y Kamikawa; Y Shimo
Journal:  Br J Pharmacol       Date:  1984-01       Impact factor: 8.739

Review 8.  Mycotoxins and the Enteric Nervous System.

Authors:  Sławomir Gonkowski; Magdalena Gajęcka; Krystyna Makowska
Journal:  Toxins (Basel)       Date:  2020-07-19       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.